237 related articles for article (PubMed ID: 27174408)
1. Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine.
Smith CT; Dang LC; Cowan RL; Kessler RM; Zald DH
Neuropharmacology; 2016 Sep; 108():394-402. PubMed ID: 27174408
[TBL] [Abstract][Full Text] [Related]
2. Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D
Pfeifer P; Tüscher O; Buchholz HG; Gründer G; Vernaleken I; Paulzen M; Zimmermann US; Maus S; Lieb K; Eggermann T; Fehr C; Schreckenberger M
Addict Biol; 2017 Sep; 22(5):1449-1458. PubMed ID: 27396374
[TBL] [Abstract][Full Text] [Related]
3. Cocaine cue-induced dopamine release in the human prefrontal cortex.
Milella MS; Fotros A; Gravel P; Casey KF; Larcher K; Verhaeghe JA; Cox SM; Reader AJ; Dagher A; Benkelfat C; Leyton M
J Psychiatry Neurosci; 2016 Aug; 41(5):322-30. PubMed ID: 26900792
[TBL] [Abstract][Full Text] [Related]
4. Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia.
Frankle WG; Himes M; Mason NS; Mathis CA; Narendran R
Biol Psychiatry; 2022 Nov; 92(10):791-799. PubMed ID: 35791965
[TBL] [Abstract][Full Text] [Related]
5. Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.
Ota M; Ogawa S; Kato K; Masuda C; Kunugi H
Neurosci Res; 2015 Dec; 101():1-5. PubMed ID: 26232153
[TBL] [Abstract][Full Text] [Related]
6. Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [
Smith CT; Dang LC; Burgess LL; Perkins SF; San Juan MD; Smith DK; Cowan RL; Le NT; Kessler RM; Samanez-Larkin GR; Zald DH
Psychopharmacology (Berl); 2019 Feb; 236(2):581-590. PubMed ID: 30350220
[TBL] [Abstract][Full Text] [Related]
7. Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.
Frankle WG; Paris J; Himes M; Mason NS; Mathis CA; Narendran R
Biol Psychiatry; 2018 Apr; 83(8):707-714. PubMed ID: 29325847
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine-induced striatal dopamine release in schizotypal personality disorder.
Thompson JL; Rosell DR; Slifstein M; Xu X; Rothstein EG; Modiano YA; Kegeles LS; Koenigsberg HW; New AS; Hazlett EA; McClure MM; Perez-Rodriguez MM; Siever LJ; Abi-Dargham A
Psychopharmacology (Berl); 2020 Sep; 237(9):2649-2659. PubMed ID: 32572588
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers.
Zakiniaeiz Y; Hillmer AT; Matuskey D; Nabulsi N; Ropchan J; Mazure CM; Picciotto MR; Huang Y; McKee SA; Morris ED; Cosgrove KP
Neuropsychopharmacology; 2019 Dec; 44(13):2205-2211. PubMed ID: 31269510
[TBL] [Abstract][Full Text] [Related]
10. Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.
Schifani C; Tseng HH; Kenk M; Tagore A; Kiang M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
Brain; 2018 Jul; 141(7):2213-2224. PubMed ID: 29860329
[TBL] [Abstract][Full Text] [Related]
11. The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding.
Zald DH; Woodward ND; Cowan RL; Riccardi P; Ansari MS; Baldwin RM; Cowan RL; Smith CE; Hakyemez H; Li R; Kessler RM
Neuroimage; 2010 May; 51(1):53-62. PubMed ID: 20149883
[TBL] [Abstract][Full Text] [Related]
12. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls.
Schrantee A; Ferguson B; Stoffers D; Booij J; Rombouts S; Reneman L
Brain Imaging Behav; 2016 Jun; 10(2):548-58. PubMed ID: 26149196
[TBL] [Abstract][Full Text] [Related]
13. Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [
Schneier FR; Slifstein M; Whitton AE; Pizzagalli DA; Reinen J; McGrath PJ; Iosifescu DV; Abi-Dargham A
Biol Psychiatry; 2018 Oct; 84(8):563-573. PubMed ID: 30041971
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.
Riccardi P; Li R; Ansari MS; Zald D; Park S; Dawant B; Anderson S; Doop M; Woodward N; Schoenberg E; Schmidt D; Baldwin R; Kessler R
Neuropsychopharmacology; 2006 May; 31(5):1016-26. PubMed ID: 16237395
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
[TBL] [Abstract][Full Text] [Related]
16. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic system dysfunction in recreational dexamphetamine users.
Schrantee A; Václavů L; Heijtel DF; Caan MW; Gsell W; Lucassen PJ; Nederveen AJ; Booij J; Reneman L
Neuropsychopharmacology; 2015 Mar; 40(5):1172-80. PubMed ID: 25394786
[TBL] [Abstract][Full Text] [Related]
18. PET imaging of dopamine-D2 receptor internalization in schizophrenia.
Weinstein JJ; van de Giessen E; Rosengard RJ; Xu X; Ojeil N; Brucato G; Gil RB; Kegeles LS; Laruelle M; Slifstein M; Abi-Dargham A
Mol Psychiatry; 2018 Jun; 23(6):1506-1511. PubMed ID: 28507321
[TBL] [Abstract][Full Text] [Related]
19. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
Kohno M; Okita K; Morales AM; Robertson CL; Dean AC; Ghahremani DG; Sabb FW; Rawson RA; Mandelkern MA; Bilder RM; London ED
Mol Psychiatry; 2016 Nov; 21(11):1554-1560. PubMed ID: 26830141
[TBL] [Abstract][Full Text] [Related]
20. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED
Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
